Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.
<h4>Background</h4>Agitation in Alzheimer's disease (AD) is common and associated with poor patient life-quality and carer distress. The best evidence-based pharmacological treatments are antipsychotics which have limited benefits with increased morbidity and mortality. There are no...
Main Authors: | Chris Fox, Monica Crugel, Ian Maidment, Bjorn Henrik Auestad, Simon Coulton, Adrian Treloar, Clive Ballard, Malaz Boustani, Cornelius Katona, Gill Livingston |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22567095/pdf/?tool=EBI |
Similar Items
-
A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia
by: Gill Livingston, et al.
Published: (2014-06-01) -
Galantamine-memantine combination effective in dementia: Translate to dementia praecox?
by: Maju Mathew Koola, et al.
Published: (2018-06-01) -
The challenge of supporting care for dementia in primary care
by: Malaz Boustani, et al.
Published: (2008-01-01) -
Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) study.
by: Monica Panca, et al.
Published: (2019-01-01) -
Agitation near the end of life with dementia: An ethnographic study of care.
by: Elizabeth L Sampson, et al.
Published: (2019-01-01)